Searched for
CLINICAL SITES
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Delhi to likely get first pet park this year as city munic revives stalled projectDelhi is set to unveil its first dedicated pet park in Jangpura later this year. The Municipal Corporation of Delhi is reviving a long-pend...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- ICMR replaces old system with single window approval for medical studiesThe Indian Council of Medical Research has introduced a unified ethics approval process for multicentre medical studies, replacing the prev...
- Cobra vs Cottonmouth: Why these two snakes are dangerous in completely different waysImagine navigating the wild terrains of Africa or Asia, where cobras lurk with their potent venom that disrupts the nervous system, leading...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- The end of microphones? AI can read your muscles to speak for youSouth Korean researchers have developed a wearable neckband that translates silent mouth movements into speech using the user's own voice. ...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- UAE introduces new worker housing rules with better facilities, hygiene standardsThe UAE is upgrading worker living conditions. New rules ensure free internet access for all. Larger housing communities will get medical s...
- Is it worth taking a fresh look at the housing finance sector? 6 housing finance stocks with upside potential of up to 18%Housing finance is one of those sectors where the macro picture is always attractive, but not so much the micro reality. At the level of th...
- In times of war: Take a risk or manage it; different, yet same. 6 small-caps from different sectors with upside potential of up to 29%Picking the right stock is easier said than done. Especially when valuations are not cheap and noise levels are high. When we say noise lev...
- JD Vance's dodgy H-1B sleight of handUS policies are impacting foreign-trained doctors. Claims of widespread H-1B visa fraud are not fully supported by government data. Recent ...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Amazon launches AI research tool to speed early-stage drug discoveryAmazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
Load More
